H uman milk, in contrast to infant formula, contains a high amount of complex oligosaccharides that are thought to benefit the breast-fed infant. In an attempt to provide formulafed infants with similar benefits, some companies started to supplement their formulas with oligosaccharides that are structurally different, but show similar prebiotic and immunomodulatory effects. Now, a study on neonatal rats reports that infant formula oligosaccharides increase bacterial translocation. This may not necessarily pose a threat for formula-fed infants, but the study raises several questions and reminds us once again that infant formula oligosaccharides are not the same as human milk oligosaccharides (HMO).HMO are, after lactose and lipids, the third most abundant component of breast milk. High concentration as well as structural diversity and complexity (Fig. 1, top) are unique to human milk. Other natural resources are unavailable and chemical or enzymatic synthesis is far too tedious and expensive for commercial use in infant formula. HMO are considered beneficial for the breast-fed infant, promoting health and preventing disease, reviewed in Ref.(1). Because infant formulas lack HMO along with their potential benefits, some infant formula-producing companies set out to search for inexpensive alternatives, and developed mixtures of galactooligosaccharides (GOS, Fig. 1, bottom left) and fructooligosaccharides (FOS, Fig. 1, bottom right) or inulin that mimic the prebiotic effects of human milk and promote a bacterial microflora that closely resembles that of breast-fed infants (2,3). GOS/FOS supplemented formulae have also been reported to modulate the immune system in mice (4) and to reduce the incidence for infectious episodes (5) and atopic dermatitis in at risk infants (6).In this issue of Pediatric Research, Barrat et al. report that a formula supplemented with GOS/inulin increases bacterial translocation in artificially reared newborn rats (7). Is there a potential risk for human infants that receive formula supplemented with these oligosaccharides?A 2003 study on adult rats infected with Salmonella enteritidis showed that a diet supplemented with FOS increased Salmonella counts and infection-induced diarrhea, and enhanced Salmonella translocation (8). In parallel, cecal lactic acid concentration increased significantly, similar to the current study with GOS/inulin. Although FOS impaired the intestinal epithelial barrier function in the original study (9), the present study did not find that colonic permeability was affected (7). The method, however, may not have been sensitive enough to detect a significant difference. Although the original FOS study assessed in vivo chromium ethylenediaminetetraacetate uptake (9), the present study used Ussing chambers and measured the flux of fluorescein isothiocyanate-dextran through nonstripped colon explants (7). The labeled dextran had to cross not only the mucosal barrier, but also submucosa, muscularis externa, and serosa or adventitia. Nevertheless, the original FOS study...